Stem Cell Research & Therapy, is now accepting research submissions for consideration in a special series focusing on cardiovascular regeneration.
The publication of these articles will be coordinated, with a series of commissioned reviews and opinions, edited by Prof Ronald Li (University of Hong Kong) and written by leaders in the field including Kenneth Boheler (National Institutes of Health, USA), Steve Oh (BTI, Singapore) and Sean Wu (Stanford University).
The series will review the current state-of-the-art stem cell-based approaches for disease modelling, drug discovery and myocardial repair, as well as the associated hurdles and potential solutions.
The deadline for submissions is 30th June 2013. Please Read more
Congratulations from all at BioMed Central to Sir John Gurdon and Shinya Yamanaka, who share the 2012 Nobel prize in physiology or medicine for “the discovery that mature cells can be reprogrammed to become pluripotent.” Once again, stem cells are a hot topic of conversation!
In 1962 John Gurdon demonstrated that adult cells retained all the necessary genetic information to recreate an organism by replacing the nucleus of a frog’s egg cell with the nucleus of a mature cell from a tadpole’s intestine, thus showing that – although specialized – adult cells were not necessarily irreversibly committed to one fate. Over forty years later Shinya Yamanaka showed that mature adult stem cells could be reprogrammed into pluripotent stem …
The progress made and problems faced in taking stem cells from the lab to the clinic is the focus of a new thematic series on clinical applications of stem cells, published by Stem Cell Research & Therapy. The series launches with three review articles; Nicholas Boulis reviews stem cell therapy for the spinal cord, Anish Majumdar and colleagues discuss the use of mesenchymal stem cells for cartilage repair in osteoarthritis and Aastrom’s experience in developing an autologous multicelluar therapy for critical limb ischemia is documented by Bartel et al.
In his introductory editorial the Series Editor, Mahendra Rao (NIH, USA), encourages readers to contribute to the discussion by commenting on the published articles …
Stem Cell Research & Therapy invites the submission of original research manuscripts for inclusion in a special series on stem cell research in the Asia-Pacific region, to be published later in 2012.
The series is edited by Oscar Lee (National Yang-Ming University, Taiwan), Songtao Shi (University of Southern California, USA), Yufang Shi and Ying Jin (Institute of Health Sciences, China), and aims to showcase the extensive and innovative work being performed in the area. Open access research articles will be published alongside a series of review and opinion pieces written by leaders in the field, including Kyung-Sun Kang, Hung-Chih Kuo and Minghao Zheng.
Edited by Rocky S Tuan and Timothy O’Brien, Stem …
Stem Cell Research & Therapy is expected to receive its first Impact Factor in June 2012, having been accepted for tracking by Thomson Reuters (ISI). The journal launched in March 2010 and recently marked its first anniversary. Congratulations to Rocky Tuan and Timothy O’Brien, the Editors-in-Chief, and the Editorial Board for ensuring such a strong start for the journal, as indicated by the fact it will be indexed from Volume 1.
In addition to outstanding open access research articles with a focus on stem cell therapeutics, such as a recent article from Deborah Sullivan’s group investigating how human multipotent stromal cells attenuate inflammation in acute lung injury, Stem Cell Research & Therapy also …
Stem Cell Research & Therapy, the home of translational research into stem cell therapeutics, recently celebrated its first anniversary. In an editorial marking the occasion, Editors-in-Chief Rocky Tuan and Timothy O’Brien look back at some of the highlights of the journal’s first year of publication.
Launched in March 2010, Stem Cell Research & Therapy publishes peer-reviewed open access research alongside high-quality commissioned content available by subscription. With stem cell research and its funding rarely out of the news, Stem Cell Research & Therapy provides an important forum for the dissemination and discussion of the results of such research. The journal published 50 articles in its first year of publication, and these have been well-accessed …